Original Article
A retrospective study of hospitalization costs of patients hospitalized for asthma exacerbation during 2013-2014 in China-Japan friendship hospital
Xing Bin, Lin Jiangtao
Published 2019-04-05
Cite as Int J Respir, 2019,39(7): 512-514. DOI: 10.3760/cma.j.issn.1673-436X.2019.07.007
Abstract
ObjectiveTo study the hospitalization costs and the influencing factors of the costs of patients hospitalized for asthma exacerbation during 2013-2014 in China-Japan friendship hospital.
MethodsThis was a retrospective study and involved patients hospitalized for asthma exacerbation in China-Japan friendship hospital during 2013-2014.Information about the demographic features and costs were collected using the pre-designed case report form.
ResultsNinety-nine asthma patients were included.The median hospitalization costs was 11 046 (4 811.0) RMB.The costs of medications accounted for 51.7% of the total costs.The costs of asthma medications accounted for only 28.6% of the total medication costs, while the costs for antibiotics accounted up to 54.8%.The patients with a more severe level of exacerbation, who were admitted to ICU, used mechanical ventilation, or had a history of hospitalization or emergency visits during the last year due to asthma exacerbations tended to cost more.
ConclusionsThe average cost of hospitalization is much higher than the yearly cost of maintenance therapy.Medication is the predominant component of the total hospitalization costs, and the costs of antibiotics make up the major part of the total medication costs.
Key words:
Asthma; Hospital costs; Inpatients
Contributor Information
Xing Bin
Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
Lin Jiangtao